Inventor

SCHOELKENS BERNWARD

DE56 patents

⚠️ This page may combine multiple inventors who share the name “SCHOELKENS BERNWARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHOELKENS BERNWARD

HOECHST AG

Enzyme-inhibiting urea derivatives of dipeptides, a process for the preparation thereof, agents containing these, and the use thereof

Aminoacid derivatives, a process for their preparation, agents containing these compounds, and the use thereof

USPA benzolyguanidines

Renin inhibitors

Decahydroisoquinoline carboxylic acids

Benzoylguanidines, a process for their preparation, their use as medicaments and medicaments containing them

Cis, endo-2-azabicyclo-[3.3.0]-octane-3-carboxylic acids, a process for their preparation, agents containing these compounds and their use

Method for making 2-azabicyclo-[3.3.0]-octane-3-carboxylic acids

Antiadhesive piperidine-and pyrrolidinecarboxylic acids

Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors

Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia

Cis, endo-2-azabicyclo-[3.3.0]-octane-5-carboxylic acids

Benzimidazole derivatives as angiotensin II receptor antagonists, pharmacticals, and treatment of hypertension therewith

Imidazole derivatives with a biphenylsulfonylurea or biphenylsulfonylurethane side chain and their use as angitensin II receptors

Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia

Renin-inhibiting amino acid derivatives

Imidazopyridine derivatives as angiotensin II receptor antagonists, pharmaceuticals, and treatment of hypertension therewith

Method for the treatment of atherosclerosis, thrombosis, and peripheral vessel disease

Substituted azoles, a process for their preparation, and their use

Substituted derivatives of octahydroindole-2-carboxylic acids

Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors

Method of treating cardiac insufficiency

Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors

Octahydroindole-2-carboxylic acids

Substituted 3,4-dihydro-2H-benzopyrans, processes for their preparation, their use and pharmaceutical products based on these compounds

Process for the preparation of cis, endo-2-azabicyclo-[3.3.0]-octane-3-carboxylic acids

Peptides with vasorelaxant, natriuretic and diuretic effects a process for their preparation, agents containing them, and their use

Fused azepinone and azocinone derivatives, processes for their preparation, agents containing them and their use, and intermediates in their preparation

Substituted derivatives of 2-azabicyclo-[3.3.0]octanes

Fluoroalkyl- and fluoroalkoxy-substituted heterocyclic bradykinin antagonists, process for their preparation, and their use

Substituted imidazoles

Substituted imidazoles, pharmaceutical compositions containing these, and the use thereof as antagonists of angiotensin II receptors for the treatment of high blood pressure

Dipeptide derivatives having an enzyme inhibitory action

Enzyme-inhibiting amino acid derivatives, a process for the preparation thereof, agents containing these, and the use thereof

Unsaturated N-benzopyranyllactams

Renin-inhibiting di- and tripeptides, a process for their preparation, agents containing them, and their use

Peptides having bradykinin antagonist action

Azole derivatives, process for their preparation and their use

Substituted benzo[b]pyrans, processes for their preparation, their use and pharmaceutical preparations based on these compounds

Hetero-imino-prostacyclins

Thienyl, thienyloxy or furyl substituted prostaglandin derivatives in the 6-keto-PGE1 series

Aminoalkyl and acylaminoalkyl ethers, process for their preparation, and their use as bradykinin receptor antagonists

Sulfur-containing heterocyclic bradykinin antagonists, process for their preparation, and their use

Bradykinin peptides with modifications at the N terminus

Benzothiazinone derivatives, and pharmaceuticals containing them

Renin-inhibiting aminodiol derivatives

Bicyclic α-iminocarboxylic acid compounds having hypotensive activity

AVENTIS PHARMA GMBH

Benzyloxy-substituted, fused N-heterocycles, processes for their preparation, and their use as bradykinin receptor antagonists

Use of inhibitors of the sodium-hydrogen exchanger for the production of a medicament for decreasing undesired effects of substrates of the heart

SANOFI AVENTIS DEUTSCHLAND

Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events